Search Result "PHA-568487"
Multiple Species Metabolism of PHA-568487, A Selective α7 Nicotinic Acetylcholine Receptor Agonist
Journal: Drug Metabolism Letters
Volume: 4 Issue: 3 Year: 2010 Page: 163-172
Author(s): F. Barclay Shilliday, Daniel P. Walker, Chungang Gu, Xiaojun Fang, Bruce Thornburgh, Gwendolyn D. Fate, J. Scott Daniels
Targeting of α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia and the Use of Auditory Sensory Gating as a Translational Biomarker
Journal: Current Pharmaceutical Design
Volume: 21 Issue: 26 Year: 2015 Page: 3797-3806
Author(s): Kenji Hashimoto
Targeting α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia
Journal: Current Pharmaceutical Design
Volume: 16 Issue: 5 Year: 2010 Page: 538-554
Author(s): Mihaly Hajos, Bruce N. Rogers
Endogenous Acetylcholine Controls the Severity of Polymicrobial Sepsisassociated Inflammatory Response in Mice
Journal: Current Neurovascular Research
Volume: 13 Issue: 1 Year: 2016 Page: 4-9
Author(s): Flávio Almeida Amaral,Caio Tavares Fagundes,Aline Silva Miranda,Vivian Vasconceios Costa,Livia Resende,Danielle da Gloria de Souza,Vania Ferreira Prado,Mauro Martins Teixeira,Marco Antonio Maximo Prado,Antonio Lucio Teixeira
Neuronal Nicotinic Acetylcholine Receptors - Targets for the Development of Drugs to Treat Cognitive Impairment Associated with Schizophrenia and Alzheimers Disease
Journal: Current Topics in Medicinal Chemistry
Volume: 10 Issue: 2 Year: 2010 Page: 144-152
Author(s): Simon N. Haydar, John Dunlop
Serotonergic and Cholinergic Strategies as Potential Targets for the Treatment of Schizophrenia
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 14 Year: 2016 Page: 2093-2116
Author(s): Agnieszka Nikiforuk
Cognitive Improvement by Activation of α7 Nicotinic Acetylcholine Receptors: From Animal Models to Human Pathophysiology
Journal: Current Pharmaceutical Design
Volume: 16 Issue: 3 Year: 2010 Page: 323-343
Author(s): Morten S. Thomsen, Henrik H. Hansen, Mikkelsen B. Timmerman, Jens D. Mikkelsen